Pharmaceutical particulars : מידע רוקחי

6.    PHARMACEUTICAL PARTICULARS
6.1    List of excipients

Purified water ,sodium chloride , 1 N hydrochloric acid , Disodium edetate dihydrate Benzalkonium chloride,

6.2    Incompatibilities

Aerovent and disodium cromoglicate inhalation solutions should not be administered simultaneously in the same nebuliser as precipitation may occur.

6.3    Shelf life

The expiry date of the product is indicated on the packaging materials.
Aerovent                                                              Proposed prescribing information Boehringer Ingelheim                                                      January 2022- Minor Update Aerovent should be used within 1 month from opening.

6.4   Special precautions for storage

Store below 25°C. Do not freeze.
6.5   Nature and contents of container

Amber glass bottle of 20 ml with dropper with screw closure.

6.6   Special precautions for disposal and other handling
For inhalation using a nebuliser following dilution

For each use, Aerovent, respirator solution, should be freshly diluted with 3 - 4 ml of an isotonic solution (e.g. sodium chloride solution 0.9%) and the diluted solution should be inhaled until it is used up. Any diluted solution remaining after inhalation must be discarded.
The duration of inhalation can be controlled by the dilution volume.

Aerovent can be administered using a range of commercially available nebulisers. Where wall oxygen is available, it is best administered at a flow rate of 6 - 8 l/min.

Aerovent, respirator solution, is suitable for concurrent inhalation with mucolytic agents such as ambroxol hydrochloride and bromhexine hydrochloride or fenoterol hydrobromide . The solution must not be taken orally.

Care must be taken not to allow the solution or mist to enter the eyes. The nebulised solution should be administered via a mouthpiece. If a mouthpiece is not available and a nebuliser mask is used, care must be taken to ensure that it fits properly. Patients who are predisposed to glaucoma should take particular care to ensure their eyes are protected during inhalation.

The solution should ideally be administered with the patient in a sitting or standing position.